Sagittarius Life Science (ROCO:3205) Cash And Cash Equivalents : NT$76.2 Mil (As of Mar. 2025)

View and export this data going back to 2005. Start your Free Trial

What is Sagittarius Life Science Cash And Cash Equivalents?

Sagittarius Life Science's quarterly cash and cash equivalents declined from Sep. 2024 (NT$105.47 Mil) to Dec. 2024 (NT$83.79 Mil) but then stayed the same from Dec. 2024 (NT$83.79 Mil) to Mar. 2025 (NT$76.22 Mil).

Sagittarius Life Science's annual cash and cash equivalents declined from Dec. 2022 (NT$189.48 Mil) to Dec. 2023 (NT$133.89 Mil) and declined from Dec. 2023 (NT$133.89 Mil) to Dec. 2024 (NT$83.79 Mil).

Sagittarius Life Science Cash And Cash Equivalents Historical Data

The historical data trend for Sagittarius Life Science's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sagittarius Life Science Cash And Cash Equivalents Chart

Sagittarius Life Science Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash And Cash Equivalents

Get a 7-Day Free Trial

394.24

255.66

189.48

133.89

83.79

Sagittarius Life Science Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash And Cash Equivalents	Get a 7-Day Free Trial															140.21	125.23	105.47	83.79	76.22

Sagittarius Life Science Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Sagittarius Life Science (ROCO:3205) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Sagittarius Life Science Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Sagittarius Life Science's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Sagittarius Life Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sagittarius Life Science Corp (ROCO:3205) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, 10-6th Floor, Nangang District, Taipei, TWN

Website

http://www.naturalbiokey.com

Sagittarius Life Science Corp is a Taiwan based company engaged in operating as a biotechnology and pharmaceutical company. Its business activity is to develop Chinese herbal medicines and supplements for the treatment of bone fractures, osteoporosis, wound healing and skin care.

Sagittarius Life Science Headlines

No Headlines